Showing 61 - 80 results of 3,515 for search '"gynecology"', query time: 0.06s Refine Results
  1. 61
  2. 62

    Validation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity Questionnaire for the Latin American Population by Ivana Leao Ribeiro, Luz Alejandra Lorca, Rodrigo Cuevas-Cid, Snehil Dixit, Nicolás Yáñez-Benavides, Francisco Ortega-Gonzalez

    Published 2022-01-01
    “…The aim of this study was to evaluate the validity and reliability of the neurotoxicity subscale of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) for the Chilean population. …”
    Get full text
    Article
  3. 63
  4. 64

    Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT by Elena Alvarez Moreno, Mar Jimenez de la Peña, Raquel Cano Alonso

    Published 2012-01-01
    “…Both PET-CT and now fMRI have proved to be very valuable tools for evaluation of gynecologic tumors. Most papers try to compare these techniques, but in our experience both are complementary in management of these patients. …”
    Get full text
    Article
  5. 65
  6. 66

    Perinatal Outcomes of Pregnant Women with Cardiac Disease at the “Ramón Gonzalez Coro” Gynecologic & Obstetric Teaching Hospital. by Yanara Gutiérrez Aliaga, Ileana Chio Naranjo, Elena Guerra Chang, Viviana de la Caridad Sáez Cantero

    Published 2011-11-01
    “…<strong><br />Method:</strong> a descriptive study with some analytic aspects was conducted in the Heart Disease and Pregnancy service of the “Ramón Gonzalez Coro’’ Gynecologic and Obstetric Teaching Hospital from 2000-2009. …”
    Get full text
    Article
  7. 67

    Association between gynecological disorders and insomnia and depression trajectories: a longitudinal study of middle-aged women by Huiyong Zhong, Fuling Zeng

    Published 2025-01-01
    “…BackgroundInsomnia and depression often receive inadequate attention regarding their association with common menopausal gynecological disorders (GDs), and there is a lack of longitudinal epidemiological evidence. …”
    Get full text
    Article
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79
  20. 80

    Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers by Daehwan Kim, Heekyung Chung, Wen Liu, Kangjin Jeong, Tugba Y. Ozmen, Furkan Ozmen, Matthew J. Rames, Sangyub Kim, Xiao Guo, Nathan Jameson, Petrus R. de Jong, Steven Yea, Laurie Harford, Jiali Li, Cara A. Mathews, Deborah B. Doroshow, Vincent J. Charles, Doris Kim, Kimberlee Fischer, Ahmed A. Samatar, Adrian Jubb, Kevin D. Bunker, Kimberly Blackwell, Fiona Simpkins, Funda Meric-Bernstam, Gordon B. Mills, Olivier Harismendy, Jianhui Ma, Mark R. Lackner

    Published 2025-01-01
    “…Abstract Upregulation of Cyclin E1 and subsequent activation of CDK2 accelerates cell cycle progression from G1 to S phase and is a common oncogenic driver in gynecological malignancies. WEE1 kinase counteracts the effects of Cyclin E1/CDK2 activation by regulating multiple cell cycle checkpoints. …”
    Get full text
    Article